L090-2077 Screening compound: 6-methyl-N-(4-methyl-1,3-thiazol-2-yl)-7-oxo-1-phenyl-1H,6H,7H-pyrazolo[4,3-d]pyrimidine-3-carboxamide

L090-2077 Screening compound: 6-methyl-N-(4-methyl-1,3-thiazol-2-yl)-7-oxo-1-phenyl-1H,6H,7H-pyrazolo[4,3-d]pyrimidine-3-carboxamide
L090-2077 Screening compound: 6-methyl-N-(4-methyl-1,3-thiazol-2-yl)-7-oxo-1-phenyl-1H,6H,7H-pyrazolo[4,3-d]pyrimidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L090-2077
6-methyl-N-(4-methyl-1,3-thiazol-2-yl)-7-oxo-1-phenyl-1H,6H,7H-pyrazolo[4,3-d]pyrimidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L090-2077

Molecular Formula

C17H14N6O2S (C17 H14 N6 O2 S)

Compound Name

6-methyl-N-(4-methyl-1,3-thiazol-2-yl)-7-oxo-1-phenyl-1H,6H,7H-pyrazolo[4,3-d]pyrimidine-3-carboxamide

IUPAC name

6-methyl-N-(4-methyl-13-thiazol-2-yl)-7-oxo-1-phenyl-1H6H7H-pyrazolo[43-d]pyrimidine-3-carboxamide

SMILES

Cc1csc(NC(c(c(N=CN2C)c3C2=O)nn3-c2ccccc2)=O)n1

InChI

InChI=1S/C17H14N6O2S/c1-10-8-26-17(19-10)20-15(24)13-12-14(16(25)22(2)9-18-12)23(21-13)11-6-4-3-5-7-11/h3-9H,1-2H3,(H,19,20,24)

InChI Key

CQFLLJJILACNCS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15118467

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

366.4

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.492

Distribution Coefficient, logD

0.400

Water Solubility, LogSw

-2.28

Polar Surface Area

71.270

Acid Dissociation Constant (pKa)

6.34

Base Dissociation Constant (pKb)

1.42

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

11.80

L090-2077 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-Inflammatory Library (24602 compounds)

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

Targeted Diversity Library (40567 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L090-2077 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L090-2077?
Check Price and Availability of L090-2077, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L090-2077 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L090-2077
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L090-2077
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L090-2077 available by request